Clinical trials Our ability to improve the treatment of breast cancer is dependent upon a strong research base, particularly information from clinical trials which can indicate the effectiveness of different treatment options and form the basis for guideline development. There is also a need for systematic reviews of clinical trials to form the basis of evidence-based guidelines for treatment. In August 1995, the Centre held an international meeting to explore interest in establishing a Breast Cancer Review Group as part of the Cochrane Collaboration, which is an international network ensuring high quality systematic reviews are completed. As a result of this meeting, the Centre has funded the establishment of a Collaborative Review Group in Breast Cancer based at the University of Sydney under the direction of Associate Professor John Simes. Work has begun on the development of databases of clinical trials, particularly in relation to advanced breast cancer, psychosocial issues and ductal carcinoma in situ.
Clinical trials depend upon participation by eligible women with breast cancer.
Currently, few Australian women participate in clinical trials. In August 1995, the Centre hosted a meeting of clinical researchers and women to explore the reasons for the low rates of participation and possible strategies for addressing them. The views or opinions stated in external resources which are links on this home page do not necessarily reflect those of the National Breast Cancer Centre.